Skip to main content
. 2020 Jan 28;8(1):e000886. doi: 10.1136/bmjdrc-2019-000886

Table 3.

Clinical characteristics according to weight-glycemia phenotype clusters 1–6

Characteristics,
mean (SD) or n (%)
All
n=1817
Weight-glycemia cluster
Cluster 1
n=618
(34.0%)
Cluster 2
n=195
(10.7%)
Cluster 3
n=509
(28.0%)
Cluster 4
n=79
(4.4%)
Cluster 5
n=137
(7.5%)
Cluster 6
n=279
(15.4%)
P value†
Lipids
 Total cholesterol (mg/dL) 169.6 (34.7) 156.2 (25.7) 154.5 (25.7) 177.0 (31.0)** 185.2 (37.6)** 207.9 (51.9)** 172.4 (29.9)** <0.0001
 HDL cholesterol (mg/dL) 55.2 (13.7) 56.5 (13.2) 57.2 (14.2) 57.0 (13.8)* 53.5 (12.6)* 50.6 (13.3)** 50.5 (12.3)** <0.0001
 LDL cholesterol (mg/dL) 96.1 (27.9) 86.6 (21.5) 83.5 (21.8)* 100.6 (26.1)** 104.9 (28.8)** 120.3 (38.4)** 103.1 (27.0)** <0.0001
 VLDL cholesterol (mg/dL) 18.2 (12.5) 13.1 (5.0) 13.8 (5.8) 19.5 (10.5)** 27.0 (16.5)** 36.5 (25.4)** 18.7 (9.4)** <0.0001
 Triglycerides (mg/dL) 92.3 (70.8) 65.6 (25.0) 68.8 (29.1) 97.7 (52.4)** 141.7 (123.4)** 195.0 (152.3)** 93.5 (47.1)** <0.0001
Blood pressure
 Systolic blood pressure (mm Hg) 106.0 (10.9) 104.9 (10.6) 102.7 (11.2)* 105.3 (10.1) 104.4 (11.4) 111.1 (9.8)** 110.2 (11.6)** <0.0001
 Diastolic blood pressure (mm Hg) 68.5 (8.9) 66.7 (8.5) 66.0 (8.9) 55.6 (23.5)** 69.2 (9.5)* 73.1 (8.2)** 71.1 (32.9)** <0.0001

All measures are from the cohort visit.

*Significant pairwise comparison to cluster 1, where q<0.05. **Significant pairwise comparison to cluster 1, where q<0.001. Controlled for the positive false discovery rate.

†Bonferroni-corrected p value for overall test of difference, based on use of analysis of variance (ANOVA), χ2 or Fisher’s exact test as appropriate.

HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very-low-density lipoprotein.